Barclays’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
125,996
-2,981
| -2% | -$29.7K | ﹤0.01% | 2512 |
|
|
2025
Q1 | $770K | Sell |
128,977
-3,917
| -3% | -$23.4K | ﹤0.01% | 2597 |
|
|
2024
Q4 | $1.02M | Buy |
132,894
+19,683
| +17% | +$151K | ﹤0.01% | 2626 |
|
|
2024
Q3 | $1.16M | Sell |
113,211
-9,064
| -7% | -$92.5K | ﹤0.01% | 2539 |
|
|
2024
Q2 | $1.81M | Sell |
122,275
-224,144
| -65% | -$3.33M | ﹤0.01% | 1775 |
|
|
2024
Q1 | $4.73M | Buy |
346,419
+33,839
| +11% | +$462K | ﹤0.01% | 1406 |
|
|
2023
Q4 | $3.42M | Sell |
312,580
-9,742
| -3% | -$107K | ﹤0.01% | 1774 |
|
|
2023
Q3 | $3.53M | Buy |
322,322
+7,442
| +2% | +$81.5K | ﹤0.01% | 1334 |
|
|
2023
Q2 | $4.17M | Buy |
314,880
+57,924
| +23% | +$767K | ﹤0.01% | 1323 |
|
|
2023
Q1 | $3.5M | Buy |
256,956
+1,995
| +0.8% | +$27.2K | ﹤0.01% | 1287 |
|
|
2022
Q4 | $4.98M | Buy |
254,961
+33,118
| +15% | +$647K | ﹤0.01% | 1122 |
|
|
2022
Q3 | $4.23M | Buy |
221,843
+192,220
| +649% | +$3.66M | ﹤0.01% | 1195 |
|
|
2022
Q2 | $610K | Sell |
29,623
-54,376
| -65% | -$1.12M | ﹤0.01% | 2439 |
|
|
2022
Q1 | $2.7M | Buy |
+83,999
| New | +$2.7M | ﹤0.01% | 1559 |
|